Boston Scientific Corporation (NYSE:BSX) stock Increased 0.47% in Most Recent Session

Truist rated the Boston Scientific Corporation (NYSE: BSX) stock “a Buy” and gave the company’s common stock a price target of $47. Truist’s estimates were contained in a research note released on Thursday, September 17, 2020. Several other experts on Wall Street have posted such reports regarding the BSX shares.According to Wolfe Research, the stock is “a Peer perform,” and set its price target at $46. Wolfe Research published their figures in a research note released to investors on Friday, September 11, 2020. Other experts at SVB Leerink have the stock’s price target at $40 price; with their rating of the stock is “a Mkt perform.” These scores were published in a research note the firm released on Wednesday, April 22, 2020.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Wall Street analysts tracking the Boston Scientific Corporation (NYSE: BSX) stock on daily basis. Out of 26 analysts, 21 deeming the stock a Buy and 2 gave it a rating of OVERWEIGHT. Another 3 recommended that BSX is a HOLD, while 0 rated it UNDERWEIGHT and the same number recommended SELL. If we look at the broader picture, the above ratings give the stock an average analyst rating of 1.70.

Boston Scientific Corporation has a market valuation of $51.75 billion and last released its earnings reports on 02/03/2021, for the quarterly period ended on 9/29/2020. The company’s revenue for the quarter stood at $2.66 billion. BSX Company also reported its earnings per share (EPS) as $0.37 for the quarter, which beat consensus estimates by analysts of $0.25 by $0.12, surprisingly 48.00% higher.

The stock market has more often than not ended up being extremely baffling, catching even some of the more experienced traders by surprise. It happens that even when results are as projected, the market sometimes just takes a sudden turn towards the opposite direction. Often such events lead to doubt and much speculation. At such time, it may pay to keep tabs on a stock’s historical price performance. Useful also would be knowledge of the stock’s trends, both the short term and long-term. Boston Scientific Corporation (NYSE: BSX) share prices have decreased by -1.14% over the past week, but are down -6.85% over prices posted in the last quarter. Going further back, the stock’s price has gone over -3.66% over the last 6 months but is up 1.06% in year-to-date trading.

A recent spot check on the stock’s support and resistance revealed that the publicly-traded Boston Scientific Corporation (NYSE: BSX) shares are trading at a price close to -8.03% lower than its 90-day high. On the other hand, the stock is +10.12% away from its low in the 90-day period. More broadly, BSX’s current price is -18.24% away from 52-week high. The price is 50.75% above from its 52-week low.

For regular shareholders interested in finding out how worthwhile it would be to invest in the company, then note that Boston Scientific Corporation has an ROE of 25.00%. An analysis will help understand that the lower the ROE figure; the worse a company is when it comes to generating profits. The term Return on Assets (ROA) is a ratio that points to a businesses’ profitability relative to overall assets. The company under our focus has a current ROA of 12.00%. If a business manages its assets well, then the ROA will be higher. However, the opposite will be true (lower returns) if that business is shown to be poor managers of their assets. A look at another ratio shows that Boston Scientific Corporation has a Return on Investment (ROI) of 6.00%. When profits exceed costs, then the ROI percentage will be positive, and analysts will rate such business as having a net gain. However, if the percentage index is negative, then the company’s costs basically outweigh profits.

Focusing on the company’s market volatility shows that it has a 1-Week Volatility index of 2.50%, and 2.13% for the month. This stock’s Average True Range (ATR) currently stands at 0.80, with the beta factor poised at 0.87. The indicator of Volatility helps exhibit the extent to which a stock is likely to plummet or climb when the rest of the market also dips or surges. If a stock has a beta score above 1, then its rate of volatility is high. Figures lower than 1, therefore, means that the stock’s volatility at that particular moment is low.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Shares of the Boston Scientific Corporation (NYSE: BSX) gained by $0.17 during Friday’s regular trading session to climb to $36.33. The company had a daily trading volume of 15.11 million shares, higher than its average intra-day trading volumes of about 13.90M shares.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Melanie Gerald
I am a previous Investment and Commercial Banker with more than 30 years involvement in the field. I have been prompting the two people and institutional customers on high return speculation techniques since 1991. MY goal is to bring financial specialists the most beneficial and freshest high profit thoughts. My exploration intends to expand returns by recognizing underestimated protections in the High Yield space.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Buy or Sell: Oceaneering International Inc. (NYSE: OII)

The increase in Oceaneering International (OII) stock price on Thursday reflects a rise in performance over the past months. The performance of the stock...

Does Gevo Inc. (GEVO) look like a good stock to buy?

HC Wainwright analysts upgraded their outlook for biofuel producer Gevo Inc. (NASDAQ: GEVO) last week. In the past month, the stock gained 20.97%. In...

Related Articles

Buy or Sell: Oceaneering International Inc. (NYSE: OII)

The increase in Oceaneering International (OII) stock price on Thursday reflects a rise in performance over the past months. The performance of the stock...

Does Gevo Inc. (GEVO) look like a good stock to buy?

HC Wainwright analysts upgraded their outlook for biofuel producer Gevo Inc. (NASDAQ: GEVO) last week. In the past month, the stock gained 20.97%. In...

Identifying Value and Future Vision in LiveRamp Holdings Inc. (RAMP) Stock

Apple's rejection of these cookies is causing major changes at LiveRamp Holdings Inc. (NYSE: RAMP). On February 16, Ramp shares were selling for $70.89...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.